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Abstract: Anxiolytic effects of alcohol participate in the reinforcing properties of the drug, in which 
nucleus accumbens (NAcc) is implicated. The opioidergic system in NAcc is considered a main pathway 
involved in the emotional responses of animals: rats microinjected with morphine in NAcc and the 
systemic administration of µ-opioid receptors (MOR) agonists yield low anxiety scores in the elevated 
plus maze (EPM), a behavioral test of anxiety. However, the specific participation of NAcc MOR in the 
anxiolytic effect of ethanol has not been studied. AC5, a cAMP-synthezising adenylyl-cyclase, is highly 
expressed in NAcc; it is negatively coupled to MOR and has been implicated in anxiety levels of animals. 
We evaluated the anxiolytic effects of an intra-gastric administration of ethanol (2.5g/kg) in animals 
subjected to EPM at 1, 4, and 8h after drug or water exposure. Locomotion was assayed with the open-
field test; we also measured accumbal AC5 and MOR mRNA levels by RT-PCR. After 1h, ethanol-
exposed animals showed anxiolytic-like behavior, as well as decreased and increased AC5 and MOR 
expression in NAcc, respectively. Intra-accumbal injection of β-funaltrexamine (FNA), a MOR 
antagonist, did not block ethanol-induced anxiolysis, rather it induced a tendency to increase anxiety 
levels in the water-exposed group. FNA partially decreased accumbal AC5 expression in ethanol-
treated rats. We concluded that AC5 in NAcc is participating in the emotional effects of ethanol; that 
MOR was not mediating the drug-induced AC5 reduction in NAcc nor the ethanol-induced anxiolysis. 
MOR only might be involved in basal levels of anxiety of animals.  
 
 
 
 
 
-After 1h ethanol-administered animals presented anxiolytic behavior 
-AC5 expression in nucleus accumbens is reduced only in animals with an acute administration 
of ethanol. 
-MOR expression in nucleus accumbens increased in response to ethanol administration after 
1h. 
-Injection of MOR antagonist in nucleus accumbens did not reverse anxiolytic behavior of 
ethanol administered animals.  
 
-FNA (MOR antagonist) partially decreased accumbal AC5 expression in ethanol-treated rats. 
 
-We concluded that AC5 in NAcc is participating in the emotional effects of ethanol. 
-MOR was not mediating the drug-induced AC5 reduction in NAcc nor the ethanol-induced 
anxiolysis.  
 
-MOR only might be involved in basal levels of anxiety of animals.  
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Anxiolytic effects of ethanol are partially related to a reduced expression of  
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ABSTRACT. 
Anxiolytic effects of alcohol participate in the reinforcing properties of the drug, in which 
nucleus accumbens (NAcc) is implicated. The opioidergic system in NAcc is considered a 
main pathway involved in the emotional responses of animals: rats microinjected with 
morphine in NAcc and the systemic administration of µ-opioid receptors (MOR) agonists 
yield low anxiety scores in the elevated plus maze (EPM), a behavioral test of anxiety. 
However, the specific participation of NAcc MOR in the anxiolytic effect of ethanol has not 
been studied. AC5, a cAMP-synthezising adenylyl-cyclase, is highly expressed in NAcc; it 
is negatively coupled to MOR and has been implicated in anxiety levels of animals. 
We evaluated the anxiolytic effects of an intra-gastric administration of ethanol (2.5g/kg) in 
animals subjected to EPM at 1, 4, and 8h after drug or water exposure. Locomotion was 
assayed with the open-field test; we also measured accumbal AC5 and MOR mRNA levels 
by RT-PCR. After 1h, ethanol-exposed animals showed anxiolytic-like behavior, as well as 
decreased and increased AC5 and MOR expression in NAcc, respectively. Intra-accumbal 
injection of β-funaltrexamine (FNA), a MOR antagonist, did not block ethanol-induced 
anxiolysis, rather it induced a tendency to increase anxiety levels in the water-exposed 
group. FNA partially decreased accumbal AC5 expression in ethanol-treated rats. We 
concluded that AC5 in NAcc is participating in the emotional effects of ethanol; that MOR 
was not mediating the drug-induced AC5 reduction in NAcc nor the ethanol-induced 
anxiolysis. MOR only might be involved in basal levels of anxiety of animals.  
Keywords: cAMP, nucleus accumbens, anxiety, opioid receptors, adenylyl cyclase. 
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1. Introduction 
One of the signs of alcohol dependence is the increased anxious behavior presented by 
animals and humans that results from hyperactivation of the central nervous system; this 
behavior is evident during drug withdrawal [1,2]. Thus, anxiolytic effects of alcohol are 
involved in the reinforcing properties of the drug: individuals with chronic stress or high 
anxiety levels may be more sensitive to the anxiolytic effects of ethanol and may show 
higher predisposition to consume alcohol than unstressed subjects. Accordingly, human and 
animal studies show that acute exposure from low-to-moderate doses of ethanol induces 
anxiolytic-like behavior [1-3]. 
The endogenous opioid system is essential in ethanol reinforcing actions and alcohol 
drinking behavior, possibly through the activation of µ or δ opioid receptors in the brain, and 
in particular in the meso-accumbens circuit [4-7]. This circuit is constituted mainly by 
dopaminergic cells located in the ventral tegmental area (VTA) and nucleus accumbens 
(NAcc), which receives fibers arising from the VTA. NAcc is implicated in reward and 
reinforcing properties of ethanol and other drugs of abuse and has crucial roles in motor 
function and emotional responses [8-10]. In fact, the performance in two animal tests for 
anxiety-like behavior, the avoidance test and the elevated plus maze (EPM), induces 
prominent Fos-like immunoreactivity in NAcc, among other areas [11]. Also the 
microinjection of morphine, GABAA and GABAB agonists into the NAcc induces 
anxiolytic-like effects when animals are tested with the EPM [12,13]. Although anxiolytic 
effects of ethanol may be mediated through activation of the GABAA receptor [1,14], other 
systems may also contribute, such as the endogenous opioid system: systemic administration 
of agonists of κ or µ-opioid receptors (MOR) produces anxiolytic actions [15,16]. In 
addition, the role of MOR in anxiolysis has been demonstrated by studying MOR-knockout 
(MOR-KO) mice, which present decreased basal anxiety-like behavior in several tests [17]. 
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The relation between the opioid system and ethanol-induced anxiolytic effects has not been 
extensively studied. The scarce existing research has been performed in MOR-KO mice. 
Some authors have found that MOR-KO mice do not present ethanol-induced anxiolytic 
effects, while others show the opposite [18,19]. Discrepancies in emotional responses to 
ethanol may be explained by differences in the route of administration of alcohol, its time of 
exposure, and the time elapsed after ethanol administration and the moment animals are 
subjected to the anxiety test.  
Intracellular cAMP levels regulate the phosphorylation of CREB transcription factor 
(cAMP response element binding protein) by the activity of protein kinase A (PKA). On the 
other hand, intracellular cAMP levels are controlled in part by its synthesis through adenylyl 
cyclase activities: adenylyl cyclase 5, AC5, is an isoenzyme highly expressed in dorsal 
striatum and NAcc [20,21] that mediates MOR signaling [22,23]. MOR is negatively 
coupled to AC5, and mRNAs of both are simultaneously expressed in NAcc [24]; this 
suggests that AC5 is an important effector for opioid receptors in this brain region [23]. AC5 
may play a key role in anxiety-related behaviors given that its genetic deletion in mice 
produces an anxiolytic phenotype [25], and also because its blockage by siRNAs limited 
only to the NAcc induces anxiolytic behavior in rodents [25].  
Alcohol consumption and acute or chronic administration of ethanol is known to affect 
the cAMP pathway in the NAcc [26,27]. Participation of accumbal CREB in anxiety 
behavior is suggested by using local viral gene transfer of a dominant negative mutant of 
CREB, which increases anxiety levels of rodents [28,29], whereas the inhibition of PKA in 
NAcc of animals does not have any effect on their anxiety-like behavior  [26]. Therefore, the 
purpose of the present study was to try to correlate changes in expression patterns of MOR 
and AC5 in the NAcc with the anxiolytic-like behavior of animals receiving an acute 
intragastric (i.g.) dose of ethanol (2.5 g/kg of body weight [b.w.]), followed by the exposure 
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of rats to the elevated plus maze test (EPM) at different times after alcohol administration. 
To evaluate the participation of accumbal MOR in anxiety behavior of ethanol-exposed 
animals and its relation to changes in AC5 expression, we injected a selective MOR 
antagonist (β-funaltrexamine, FNA) into the NAcc of ethanol or water-administered 
animals.  
2. Materials and methods 
2.1 Animals and treatment 
All experiments were conducted in accordance to the National Institute of Health’s 
Guide for the Care and Use of Laboratory Animals (NIH publications No. 80-23, revised 
1996). Adult male Wistar rats (250 – 300 g b.w.), fed ad libitum (Purina Chow) and 
maintained in a 12h light-dark cycle, received a single acute dose of ethanol (2.5 g/kg b.w.) 
or distilled water by oral administration with an intragastric cannula, as previously reported 
[30]. To diminish stress, animals were habituated to the cannula by a daily oral 
administration of distilled water (5 ml/kg b.w.) during 7 days previous to the experiment. 
The ethanol solution (31.5% v/v) was prepared by diluting 2.5 g ethanol in distilled water to 
a final volume of 10 ml. To evaluate anxiety-like behavior, animals were subjected to the 
elevated plus maze (EPM) for 10 min, at 1, 4, or 8 h (n=8-10 animals/group) after water or 
ethanol administration.  Locomotion of all rats was assessed by their performance in the 
open field test for 5 min; immediately after they were decapitated. Brains were removed and 
frozen on dry ice (-70°C) until analyzed.  MOR and AC5 mRNA levels in the NAcc of all 
animals subjected to EPM after water or ethanol treatment were evaluated by RT-PCR. 
2.2. Elevated plus maze (EPM) 
The EPM has been described in detail elsewhere [31]. Briefly, the experimental device 
consists of an elevated (40 cm above the floor) plus-shaped maze placed in a room 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
illuminated by a 40-W red light bulb. The maze comprises four perpendicular arms, 50 cm 
long and 10 cm wide. Two opposing arms are surrounded by 40-cm-high, white, opaque, 
plastic walls (closed arms), while the open arms lack walls. The animal was placed in the 
center of the maze facing a closed arm. An entry into an arm was determined when the 
animal placed all four paws inside this part. The cumulative time spent in the open arms, the 
number of entries made into the open arms, and the total number of crossings was video-
recorded over a 10-min session by a digital camera. Data are expressed as the percentage of 
the total time spent in the open arms, total number of entries into the open arms (these two 
parameters reflect anxiety levels), and total arm entries. The latter is a measure of the 
exploratory behavior of animals.  
2.3. Open-field test 
 In order to evaluate non-specific actions of drug treatment on general activity, 
locomotion was tested using the open-field test in all animals previously subjected to the 
EPM. The apparatus consists of an opaque-Plexiglas box (40 x 30 x 20 cm) with the floor 
divided into 12 equal squares (11 x 11 cm). Animals were placed in a corner of the box and 
an observer, blind to the pharmacological treatments, registered the number of times the 
animal crossed squares during a 5-min session [32]. 
2.4. Stereotaxic surgery for MOR antagonist injection   
For the bilateral infusion of -funaltrexamine (FNA: a MOR-antagonist; 4µg/0.3 µl) 
into the NAcc, rats were anesthetized with ketamine (0.45 ml/kg) and xylazine (0.2 ml/kg) 
and placed in a stereotaxic instrument (TSE, Systems Germany). Coordinates for the NAcc 
were: AP=1.4 mm from lambda, L=+/-1.5 mm with respect to the midline and H=-6.9 mm 
from the skull surface [33]. Vehicle or FNA administration was applied through a cannula 
attached to a Hamilton syringe (0.1 μl/min), the cannula was left for 3 min before removal to 
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prevent drug or vehicle to be drawn back by capillarity. The drill hole was covered with 
bone wax after the administration of antibiotic powder (sulfatiazol®), and the skin was 
sutured.  
FNA was prepared in 15% cyclodextran-0.9% saline (vehicle) solution. Dose and 
latency were taken from studies showing that FNA reduces MOR binding by 49% at 24 
hours, and that the decrease persists for up to 11 days [34]. This FNA dose in the NAcc is 
also able to block feeding effects induced by DAMGO, a MOR agonist [35]; this agonist can 
induce an anxiolytic-like effect by intra-amygdalar administration [36]. Five days after the 
injection of FNA or vehicle (V), animals received the i.g. administration of water: FNA+W 
and V+W groups or ethanol (2.5 mg/Kg of b.w.): FNA+Et and V+Et groups. After 1h, all 
the animals were subjected to the EPM and then decapitated. Brains were excised to 
evaluate AC5 mRNA levels in NAcc. 
2.5. Tissue collection and sample preparation 
Frozen brains were coronally sliced by hand between 2.3 and 1.3 mm from bregma, 
according to Paxinos and Watson [33]. Subsequently, a square of tissue (1 mm
2
) containing 
the anterior commissure was obtained from the right hemisphere to extract the NAcc, 
including the shell and core sub-regions, and maintained at -70C until MOR and AC5 
mRNA levels were determined by RT-PCR. A total of 4-8 animals/group/time of sacrifice 
(1, 4 and 8h) that performed the EPM behavioral test were used and their brains were kept 
frozen until biochemical determinations.  
2.6. Semi-quantification by RT-PCR 
Frozen brain regions were homogenized in 4M guanidine thyocianate (ICN, Aurora, 
OH, USA) and total RNA was extracted as described elsewhere [37]. MOR and AC5 
mRNAs were quantified by reverse transcriptase-polymerase chain reaction (RT-PCR) using 
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two different control transcripts: glyceraldehyde 3-phosphate dehydrogenase (G3PDH) and 
cyclophilin. Analysis of gene expression was performed using 4 µl of cDNA and G3PDH 
mRNA as a control, as previously reported [38,39], except that 50 pmol per tube of G3PDH 
primers (sense: 5’ TGAAGGTCGGTGTCAACGGATTTGGC and antisense: 
CATGTAGGCCATGAGGTCCACCAC) and 21 cycles were used. A 257 bp fragment 
corresponding to nucleotides 165-422 of cyclophilin cDNA was also amplified for 21 cycles 
using 50 pmol per tube of primers, whose sequences were:  5’ 
GGGGAGAAAGGATTTGGCTA (sense) and 5’ACATGCTTGCCATCCAGCC 
(antisense). The sequences of MOR primers were: 5’TAATGGCTGTGACCATGGAA 
(sense) and 5’CGACTGCTCAGACCCCTTAG (antisense). The sequences of AC5 primers 
were: 5’CGAGGTCTCCCAGAGACAAG (sense) and 5’TCAGCAAACAGGATGCTCAC 
(antisense). Final PCR conditions were 31 cycles for MOR and 32 cycles for AC5. Each 
cycle consisted of 1 min at 95
º
C followed by 1 min at 64
º
C, and 1 min at 72
º
C. All cDNAs 
had a final extension step of 10 min at 72
º
C. The resulting cDNAs were quantified from the 
same RT reaction.     
PCR products (10 µl of MOR and AC5) and 4 µl G3PDH or 4 µl cyclophilin were 
separated by electrophoresis in a 2% agarose (Ultra-pure Bio-Rad, Hercules, CA, USA) gel 
stained with ethidium bromide (1mg/L). Densities were measured with the Advanced 
American Biotech Imaging software (American-Applied Biotechnology, Fullerton, CA, 
USA). The relative amounts of MOR and AC5 mRNAs were calculated as the ratio between 
MOR or AC5 and that of its control amplicon.  
2.7. Statistical analysis 
A two-way ANOVA was performed to evaluate behavioral and gene expression data at 
different times of ethanol or water administration; this test was also used to analyze the 
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results of anxiety-like behavior and AC5 mRNA levels in animals injected with MOR 
antagonist (FNA) or vehicle in the NAcc. Significant differences between groups were 
analyzed by the post-hoc Student Newman Keul’s test in the case of the behavioral data. 
Specific paired comparison was performed with a Student’s t-test when necessary. 
Significance was considered at p<0.05. 
3. Results 
3.1 Behavioral tests. 
We analyzed the anxiolytic effect after acute ethanol (2.5 g/kg i.g.) administration in 
animals performing the EPM test. A t-test indicated a significant increase in the time spent 
by animals in the open arms after 1h (t=3.18, df=15, p<0.006) of ethanol administration 
when compared to controls (Fig. 1A). A decrease in the time spent in the closed arms 
(t=3.36, df=15, p=0.01) (Fig. 1B) was observed, as well as an increase in the total number of 
entries (t=-2.28, df=15, p<0.05) (Fig. 1C). No anxiolytic-like effects were observed at other 
evaluation times after ethanol administration.  
Acute ethanol administration did not alter motor activity of treated animals subjected to 
the open field test at any time (Table 1). These results indicate that the increased time spent 
in the open arms by ethanol-treated animals was not due to increased locomotor activity. 
3.2 MOR and AC5 mRNA levels in nucleus accumbens. 
Statistical analysis of MOR mRNA levels showed a significant main effect of time 
[F(2,46)=39.425, p<0.0001], treatment [F(1,46)=16.668, p<0.0001], and interaction between 
these factors [F(2,46)=42.612, p<0.0001]. Ethanol increased MOR mRNA levels by 33 ± 5%, 
1h after administration, followed by decreases of 28 ± 6% (4h) and 53 ± 8%  (8h) (Fig. 2A). 
A two-way ANOVA of AC5 mRNA expression showed a significant main effect of time 
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[F(2,48)=92.825, p<0.0001], treatment [F(1,48)=25.029, p<0.0001] and time x treatment 
interaction [F(2,48)=92.825, p<0.0001]. AC5 mRNA levels decreased by 54 ± 2% at 1h, 
followed by an increase of 87 ± 11% at 4h and an increase of 30 ± 2% at 8h after ethanol 
exposure (Fig. 2B).  
3.3. Anxiety-like behavior of ethanol-administered animals injected with MOR antagonist in 
the NAcc. 
Vehicle-injected animals in the NAcc and administered with ethanol (V+Et) showed 
longer time spent in the open arms in the EPM test (52 ± 10%) when compared to water-
administered rats, V+W group (20 ± 7%, p<0.001). These results confirmed the anxiolytic 
effect of ethanol treatment after 1h. Animals injected with FNA in the NAcc and 
administered with ethanol (FNA+Et) also showed an increase in the time spent in the open 
arms when compared to their controls (FNA+W). These results showed that MOR 
antagonist was not able to reverse the anxiolytic effect induced by ethanol (Fig 3A). 
Although FNA injection seemed to reduce the time spent in the open arms of the FNA+W 
group in comparison to V+W animals, the decrease was not significant. Thus, MOR 
blockade showed a tendency to induce anxiety at basal level. A two-way ANOVA showed  
main effect of ethanol administration [F(1,34)=18.79, p<0.001], but not of FNA injection 
[F(1,34)=1.07, ns] or of the interaction between ethanol and FNA treatment [F(1,34)=0.49, ns].  
The time spent in the closed arms in the EPM test was reduced in ethanol-administered 
groups in comparison with their controls: V+Et = 45 ± 11% vs. V+W= 77 ± 7%, p<0.05, 
and FNA+Et= 45 ± 9% vs. FNA+W= 90 ± 5, p<0.05. A two-way ANOVA showed a 
significant effect of ethanol treatment [F(1,34)=18.93, p<0.001], but not of FNA  [F(1,34)=0.6, 
ns], or of the interaction between variables [F(1,34)=0.47, ns] (Fig 3B). 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
11 
 
The total number of entries to both compartments of the maze for ethanol-administered 
animals was not affected by FNA injection (Fig. 3C): (V+Et) = 7 ± 2% vs. (V+W) = 3.2 ± 
0.7%, p<0.05, and (FNA+Et) = 6.4 ± 1.6% vs. (FNA+W) = 1.7 ± 0.7%, p<0.01. A two-way 
ANOVA showed an effect of ethanol treatment [F(1.34)=7.82, p <0.01], but no effect of FNA 
treatment [F(1,34)=0.50, ns], or the interaction between ethanol and FNA treatment 
[F(1,34)=0.06, ns]. 
3.4 AC5 mRNA levels in response to the injection of MOR antagonist in nucleus accumbens. 
A two-way ANOVA of AC5 mRNA levels in the NAcc of V+W or V+Et animals and of 
groups injected with vehicle or FNA (FNA+W, FNA+Et) indicated a significant effect of the 
antagonist injection  [F(1,34)=15.500, p<0.001] and of ethanol administration [F(1,34)=29.191, 
p<0.001], but not of the interaction between ethanol and FNA treatment [F(1,34)= 1.191, ns]. 
Ethanol decreased AC5 mRNA levels to 33 ± 3%, 1h after administration, in V+Et vs. V+W 
group (100%)(Fig. 4), which confirmed the observed decrease in enzyme expression in the 
first trial (kinetics). AC5 mRNA levels in FNA+Et animals decreased 19% vs. FNA+W 
group. FNA increased AC5 mRNA expression (28%) in FNA+Et animals when compared to 
the V+Et group. Thus, MOR blockage was not enough to reverse the decrease induced by 
ethanol on enzyme synthesis.  
4. Discussion 
Ethanol administration reduced anxiety levels only in animals tested 1h after drug 
exposure. This might correspond to the increased ethanol content in blood (518 mg/l) at 30 
min that is maintained elevated (370 mg/l) up to 2h, and undetectable after 8h, as has been 
described [30].  Thus, it was not surprising that groups of ethanol-administered animals after 
4 and 8h had similar anxiety levels than those administered with water. Also, the total 
number of arm entries was increased in ethanol-treated animals; these data could be 
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interpreted as an increase in their overall activity instead of an anxiolytic-like effect [40]. 
However, when we evaluated the locomotion of animals in the open field test, we found no 
differences between groups at any time. Moreover, the increase in the time spent in the open 
arms of the EPM, 1h after drug administration, corresponded to the short time spent by 
animals in the closed arms at the same moment.   
 
Expression of MOR and AC5 in NAcc of ethanol-administered animals. 
We observed that MOR mRNA levels increased, whereas those of AC5 decreased in the 
NAcc of the group of ethanol-administered animals that presented anxiolytic behavior (1h 
post-treatment). We interpret MOR up-regulation as the activation of the receptors, given 
that an opioid agonist administration increases MOR mRNA levels [41]. An active release 
of endogenous opioid peptides (β-endorphin and methionin-enkephalin) in the NAcc 
induced by ethanol, which has been well documented [42-44], might be involved in the 
increase in MOR mRNA levels. Our results suggest that the anxiolytic-like behavior of 
ethanol-exposed animals might be related to MOR stimulation in the NAcc. This would be 
important since the participation of accumbal opioidergic system in anxiolysis has been only 
proposed by the injection of non-specific agonists of opioids receptors [13], but the role of 
MOR in the NAcc has not been evaluated. Thus, in a second experiment we tested the role 
of accumbal MOR in emotional actions of alcohol by injecting FNA, a specific MOR 
antagonist, into the NAcc of animals. 
AC5 mRNA levels were decreased in ethanol-treated animals which presented 
anxiolytic behavior (1h). Our data are in agreement with studies showing that the blockage 
of AC5 expression in NAcc by injecting siRNA-AC5 induces lower anxiety scores than 
controls, when animals perform the EPM [25]. The decreased expression in MOR along 
with high AC5 mRNA levels found after 4-8h post-ethanol (when animals showed normal 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
13 
 
anxiety levels) suggest that the drug might have affected AC5 expression through the 
stimulation of the opioidergic system in NAcc and that those changes may be involved in 
ethanol-induced anxiolysis. Further experiments invalidated this hypothesis.  
 
MOR antagonist injection into the NAcc.  
To analyze whether ethanol-induced anxiolytic-like effect in animals after 1h post-
treatment was indeed related to the reduced AC5 expression through MOR activation, we 
injected a MOR specific antagonist (FNA) into the NAcc of water- and ethanol-administered 
animals. We found that blocking MOR in NAcc was not able to reverse the anxiolytic effect 
of ethanol. However, control animals injected with FNA (FNA+W) had a tendency to reduce 
their entrance to the open arms of the maze, which suggested that MOR of NAcc was 
required to regulate basal anxiety levels as has been proposed [17], but were not related to 
the anxiolytic effects of ethanol. 
It is important to consider that our results are not comparable to those performed in 
MOR KO animals that show insensitivity to the anxiolytic-like effects of ethanol [19], since 
we are blocking MOR specifically in the NAcc. Other brain regions such as the extended 
amygdala are important for anxiety-like behavior [45,46]. This superstructure extends from 
the central nucleus of the amygdala (CeA) to the bed nucleus of the stria terminalis (BNST). 
Thus, our results suggest that MOR may play a relevant role in the anxiolytic actions of 
ethanol in other regions of the extended amygdala, as has been shown [36]. MOR in the 
NAcc, in contrast, may be participating in behaviors other than anxiety that are altered by 
ethanol, such as locomotion, reward, or analgesia [23]. 
Injection of the MOR antagonist partially blocked the reduction of AC5 induced by 
ethanol exposure, given that enzyme mRNA levels were still decreased in the FNA+Et 
group in comparison to that of its own control (FNA+W). These results suggest that ethanol 
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was able to reduce AC5 expression in NAcc not only through MOR, but also through the 
activation of other receptors of neurotransmitters or peptides that are negatively coupled to 
AC5, such as dopamine D2. Animals exposed to ethanol either injected or not with FNA in 
the NAcc, presented lower anxiety scores and reduced AC5 expression vs. their respective 
controls. Thus, we cannot discard the participation of AC5 in the anxiolytic actions of the 
drug, although it would not be related to MOR activation.  
We conclude that AC5 expression in the NAcc is a target of acute ethanol effects. Our 
results suggest that MOR in NAcc is participating in basal levels of anxiety of animals. In 
contrast, we observed that the anxiolytic effect of ethanol was not due to MOR activation, 
nor to MOR-induced AC5 reduction in NAcc. However, AC5 in NAcc is participating in the 
emotional effects of the drug. It is also possible that the observed changes in AC5 and MOR 
expression by ethanol administration in the NAcc may be participating in different behaviors 
other than anxiety, such as reward or analgesia, that are triggered by the drug in this brain 
region [23].  
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Figure legends 
Figure 1. Effect of acute ethanol administration on anxiety-related behavior of animals 
subjected to the elevated plus maze test. Male Wistar rats received a single acute dose of 
ethanol (2.5 g/kg body weight i.g.) or distilled water and were subjected to the behavioral 
test 1, 4, or, 8 h after treatment. White bars represent control animal parameters and black 
bars represent ethanol-treated animal parameters. A) Percentage of time spent in the open 
arms (controls=100%). B) Percentage of time spent in the closed arms (controls=100%). C) 
Number of total entries/10 min. Data are expressed as the percentage of time spent in the 
open arms or in closed arms vs. control (total time spent in both compartments=100%); data 
are the mean ± SEM of 8 animals. *p<0.050, **p<0.010.   
Table 1. Effect of ethanol administration on the locomotor activity. Locomotor activity was 
counted after a single acute dose of ethanol (2.5 g/kg i.g.) or distilled water in Wistar rats. 
Locomotor activity was evaluated with the open-field test. Data represent the mean ± S.E.M. 
of 8 animals.  The apparatus registers the number of times the animal crosses squares during 
a 5-min session.   
Figure 2. Effect of acute ethanol administration on gene expression in the nucleus 
accumbens. Animal treatment was performed as described in Fig.1. Rats were sacrificed 
1:15, 4:15 and 8:15 h after ethanol or water administration and their brains removed. Gene 
expression was performed by RT-PCR. White and black bars represent control and ethanol-
treated animal values, respectively.  A) MOR mRNA levels and B) AC5 mRNA levels. Data 
are the ratio between each cDNA (MOR or AC5) and cyclophilin cDNA and expressed as 
the mean ± SEM calculated as the percentage of control values (C=100%) of 9 animals. *p< 
0.01, **p<0.0001 vs. values of water-administered animals. Significant differences were 
also observed between ethanol-treated animals in the nucleus accumbens: # significantly 
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different vs. ethanol-treated animals after 1h; + significantly different vs. ethanol-treated 
animals after 4h.  
Figure 3. Effect of funaltrexamine injected bilaterally into the nucleus accumbens of rats that 
showed an anxiolytic-like effect 1h after acute ethanol treatment. Animals were subjected to 
the elevated plus maze test after receiving a single acute dose of ethanol (2.5 g/kg body 
weight i.g.) or distilled water (1h post-treatment). White bars represent control animal 
parameters and black bars represent ethanol-treated animal parameters. A) Percentage of 
time spent in the open arms (controls=100%). B) Percentage of time spent in the closed arms 
(controls=100%). C) Number of total entries/10 min. Data are expressed as the percentage of 
time spent in the open arms or in closed arms vs. control (total time spent in both 
compartments=100%); data are the mean ± SEM of 9-10 animals. *p<0.050, **p<0.010, 
***p<0.001.  
Figure 4. Effect of funaltrexamine on AC5 mRNA levels in the nucleus accumbens in 
animals that showed anxiolytic-like effect 1h after acute ethanol treatment. Animal treatment 
was performed as described in materials and methods. Rats were sacrificed 1:15, after 
ethanol or water administration and their brains removed. Gene expression was performed 
by RT-PCR. White and black bars represent control and ethanol-treated animal values, 
respectively.  Data are the ratio between AC5 cDNA and cyclophilin cDNA and expressed 
as the mean ± SEM calculated as the percentage of control values (C=100%) of 9-10 
animals. *p<0.0001 vs. values of water-administered animals.  
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Treatments Time # Squares/5 min 
Control 
Ethanol 
1 h 
1 h 
50.0 ± 11.3 
50.8 ± 7.0 
Control 
Ethanol 
4 h 
4 h  
32.2 ± 3.1 
36.0 ± 3.1 
Control 
Ethanol 
8 h 
8 h 
39.0 ± 4.1 
42.6 ± 4.4 
Table(s)
